These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 13170026)
21. [Endangiitis obliterans considered as a systemic disease in the light of some clinical and laboratory findings]. CERRINI L; BARDI F Osp Maggiore; 1953 Apr; 41(4):169-74. PubMed ID: 13088134 [No Abstract] [Full Text] [Related]
22. [Biochemical and anatomico pathological study of the musculature of the extremities in chronic peripheral circulatory disorders, particularly in endangitis obliterans]. DODEN W; HILLENBRAND HJ; MENNE F; RODECK H; WOLK N Klin Wochenschr; 1951 Jul; 29(25-26):433-4. PubMed ID: 14851671 [No Abstract] [Full Text] [Related]
23. [The relationships of the eye vessels to endangiitis obliterans von v. Winiwarter citizens]. SCHMID AE; von ALBERTINI A Ophthalmologica; 1947 Mar; 113(3):129-48. PubMed ID: 20342265 [No Abstract] [Full Text] [Related]
27. [Endarteritis obliterans and obliterating arteriosclerosis of the abdominal aorta]. SITENO VM Vopr Neirokhir; 1949; 13(4):5-11. PubMed ID: 18140027 [No Abstract] [Full Text] [Related]
28. [Studies on arteriosclerosis and endangitis obliterans. II. Glycogen content of the skeletal musculature in chronic peripheral circulatory disorders]. SCHMIDT CG; HILLENBRAND HJ Z Gesamte Exp Med; 1953; 121(5):480-7. PubMed ID: 13137186 [No Abstract] [Full Text] [Related]
29. [Studies on arteriosclerosis and endangitis obliterans. III. Behavior of phosphomonoesterases in skeletal musculature in peripheral vascular disorders]. SCHLIEF H; SCHMIDT CG; HILLENBRAND HJ Z Gesamte Exp Med; 1954; 122(5):409-15. PubMed ID: 13170019 [No Abstract] [Full Text] [Related]
30. [Prevention and therapy of endarteritis obliterans]. KHODKOV VN Med Sestra; 1954 Oct; (10):17-21. PubMed ID: 13235086 [No Abstract] [Full Text] [Related]
31. [Studies on arteriosclerosis and endangitis obliterans. VIII. Hexokinase and adenosine triphosphatase in skeletal muscles in peripheral vascular disorders]. SCHLIEF H; SCHMIDT CG; HILLENBRAND HJ Z Gesamte Exp Med; 1955; 125(4):379-85. PubMed ID: 14386906 [No Abstract] [Full Text] [Related]
32. [Prevention of endarteritis obliterans]. SHABANOV AN Sov Med; 1953 Apr; 17(4):24-7. PubMed ID: 13064646 [No Abstract] [Full Text] [Related]
39. [Endarteritis obliterans of the arm]. MATHIEU L; HADOT S Rev Med Nancy; 1955 Nov 1-15; 80():902-18. PubMed ID: 13290462 [No Abstract] [Full Text] [Related]
40. [Organization of prevention and therapy of endarteritis obliterans]. SHUBIN VN Khirurgiia (Mosk); 1953 Mar; 70(3):61-3. PubMed ID: 13062432 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]